Published in J Clin Invest on April 15, 1996
Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension (2009) 4.26
Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest (1999) 2.09
The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest (1997) 2.05
Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest (1997) 1.83
Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci U S A (1999) 1.60
Angiotensin AT2 receptors: cardiovascular hope or hype? Br J Pharmacol (2003) 1.34
New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II. Peptides (2011) 1.32
Angiotensin AT₂ receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension (2010) 1.23
AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function. Pflugers Arch (2012) 1.10
Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide. Br J Pharmacol (2003) 1.10
The uterine placental bed Renin-Angiotensin system in normal and preeclamptic pregnancy. Endocrinology (2009) 1.08
Nonclassical renin-angiotensin system and renal function. Compr Physiol (2012) 1.02
Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats. Am J Physiol Regul Integr Comp Physiol (2008) 0.98
Angiotensin II and nitric oxide interaction. Heart Fail Rev (2002) 0.98
Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney. Am J Physiol Regul Integr Comp Physiol (2011) 0.97
The intrarenal renin-angiotensin and dopaminergic systems: control of renal sodium excretion and blood pressure. Hypertension (2013) 0.96
Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor. J Clin Invest (1999) 0.96
Furosemide-induced renal medullary hypoperfusion in the rat: role of tissue tonicity, prostaglandins and angiotensin II. J Physiol (2005) 0.96
Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J Clin Invest (1997) 0.95
International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. Pharmacol Rev (2015) 0.94
Angiotensin II type-2 receptor-specific effects on the cardiovascular system. Cardiovasc Diagn Ther (2012) 0.94
The angiotensin II type 2 receptor and the kidney. J Renin Angiotensin Aldosterone Syst (2009) 0.92
Differential effect of angiotensin II on blood circulation in the renal medulla and cortex of anaesthetised rats. J Physiol (2002) 0.90
Reinforcing feedback loop of renal cyclic guanosine 3' 5' -monophosphate and interstitial hydrostatic pressure in pressure-natriuresis. Hypertension (2009) 0.88
Receptor-induced dilatation in the systemic and intrarenal adaptation to pregnancy in rats. PLoS One (2009) 0.87
Arachidonic acid mediates angiotensin II effects on p21ras in renal proximal tubular cells via the tyrosine kinase-Shc-Grb2-Sos pathway. Proc Natl Acad Sci U S A (1998) 0.86
Regulation of renal 12(S)-hydroxyeicosatetraenoic acid in diabetes by angiotensin AT1 and AT2 receptors. Am J Physiol Regul Integr Comp Physiol (2008) 0.85
Hypercalcemia stimulates expression of intrarenal phospholipase A2 and prostaglandin H synthase-2 in rats. Role of angiotensin II AT1 receptors. J Clin Invest (1997) 0.85
The Angiotensin II Type 2 Receptor in Brain Functions: An Update. Int J Hypertens (2012) 0.85
How does angiotensin AT(2) receptor activation help neuronal differentiation and improve neuronal pathological situations? Front Endocrinol (Lausanne) (2012) 0.85
Role of angiotensin AT(2) receptors in natriuresis: Intrarenal mechanisms and therapeutic potential. Clin Exp Pharmacol Physiol (2013) 0.83
Angiotensin 1-7 Receptor and Angiotensin II Receptor 2 Blockades Prevent the Increased Serum and Kidney Nitric Oxide Levels in Response to Angiotensin II Administration: Gender-Related Difference. Int J Prev Med (2013) 0.83
Differential regulation by AT(1) and AT(2) receptors of angiotensin II-stimulated cyclic GMP production in rat uterine artery and aorta. Br J Pharmacol (2004) 0.83
AT2 receptor activities and pathophysiological implications. J Cardiovasc Pharmacol (2015) 0.83
Cardiovascular and cerebrovascular outcomes in elderly hypertensive patients treated with either ARB or ACEI. J Geriatr Cardiol (2012) 0.81
Role of ACE/AT2R complex in the control of mesenteric resistance artery contraction induced by ACE/AT1R complex activation in response to Ang I. Mol Cell Biochem (2007) 0.80
Compartmentalization of extracellular cGMP determines absorptive or secretory responses in the rat jejunum. J Clin Invest (1999) 0.79
The bradykinin BK2 receptor mediates angiotensin II receptor type 2 stimulated rat duodenal mucosal alkaline secretion. BMC Physiol (2003) 0.79
Emerging role of angiotensin type 2 receptor (AT2R)/Akt/NO pathway in vascular smooth muscle cell in the hyperthyroidism. PLoS One (2013) 0.79
A nonpeptide angiotensin II type 2 receptor agonist prevents renal inflammation in early diabetes. J Cardiovasc Pharmacol (2015) 0.78
Gender Difference in Renal Blood Flow Response to Angiotensin II Administration after Ischemia/Reperfusion in Rats: The Role of AT2 Receptor. Adv Pharmacol Sci (2016) 0.77
Angiotensin receptors modulate the renal hemodynamic effects of nitric oxide in conscious newborn lambs. Physiol Rep (2014) 0.77
Evaluation of analgesic activity of perindopril in albino mice. J Adv Pharm Technol Res (2014) 0.77
The interaction of nitric oxide, bradykinin, and the angiotensin II type 2 receptor: lessons learned from transgenic mice. J Clin Invest (1999) 0.76
The effect of angiotensin II microinjection into the bed nucleus of the stria terminalis on serum lipid peroxidation and nitric oxide metabolite levels. Adv Biomed Res (2016) 0.75
Angiotensin type 1 receptor mediates renal production and conversion of prostaglandins E2 to F2α in conscious diabetic rats. J Renin Angiotensin Aldosterone Syst (2015) 0.75
High-fat diet amplifies renal renin angiotensin system expression, blood pressure elevation, and renal dysfunction caused by Ceacam1 null deletion. Am J Physiol Endocrinol Metab (2015) 0.75
The curtain rises on the renin-angiotensin system: AT2 receptors are in the spotlight. J Clin Invest (1996) 0.75
Interaction of the renin angiotensin and cox systems in the kidney. Front Biosci (Schol Ed) (2016) 0.75
The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases. Pharmacol Res (2017) 0.75
Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev (1991) 42.38
Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution. J Cyclic Nucleotide Res (1975) 6.71
Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins (1980) 2.78
Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest (1994) 1.59
Contribution of the renin-angiotensin system to the control of intrarenal hemodynamics. Kidney Int (1984) 1.48
Subclasses of angiotensin II binding sites and their functional significance. Mol Pharmacol (1990) 1.48
Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition. Hypertension (1995) 1.42
Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted rat. Eur J Pharmacol (1993) 1.26
Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats. J Clin Invest (1995) 1.22
Angiotensin II receptor subtypes in cultured rat renal mesangial cells. Am J Physiol (1992) 1.18
In vitro autoradiography reveals predominantly AT1 angiotensin II receptors in rat kidney. Ren Physiol Biochem (1992) 1.13
Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin. J Clin Invest (1981) 1.12
Rat renal interstitial bradykinin, prostaglandin E2, and cyclic guanosine 3',5'-monophosphate. Effects of altered sodium intake. Hypertension (1994) 1.10
Localization and properties of angiotensin II receptors in rat kidney. Kidney Int Suppl (1993) 1.05
Renal hemodynamic and excretory responses to PD 123319 and losartan, nonpeptide AT1 and AT2 subtype-specific angiotensin II ligands. J Pharmacol Exp Ther (1992) 0.99
Dual effects of bradykinin on prostaglandin metabolism: relationship to the dissimilar vascular actions of kinins. Prostaglandins (1977) 0.97
Cyclic AMP and the regulation of prostaglandin production by macrophages. Biochem Biophys Res Commun (1983) 0.96
Stimulation of renal interstitial bradykinin by sodium depletion. Am J Hypertens (1993) 0.96
Cyclic GMP and regulation of cyclic nucleotide hydrolysis. Adv Pharmacol (1994) 0.95
Role of angiotensin AT1 and AT2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog. Br J Pharmacol (1993) 0.91
Localization of cGMP after infusion of ANP or nitroprusside in the maturing rat. Am J Physiol (1992) 0.89
Plasma renin activity during pentobarbital anesthesia and graded hemorrhage in dogs. Am J Physiol (1975) 0.88
The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest (1997) 2.05
Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension (1997) 1.77
Reductive assays for S-nitrosothiols: implications for measurements in biological systems. Biochem Biophys Res Commun (1998) 1.68
Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci U S A (1999) 1.60
Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol (1989) 1.55
Recruitment of renin gene-expressing cells in adult rat kidneys. Am J Physiol (1990) 1.50
Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension (1999) 1.50
Vascular endothelial growth factor induces nephrogenesis and vasculogenesis. J Am Soc Nephrol (1999) 1.48
Dopamine-induced recruitment of dopamine D1 receptors to the plasma membrane. Proc Natl Acad Sci U S A (1998) 1.45
Distribution of renin mRNA and its protein in the developing kidney. Am J Physiol (1989) 1.45
Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition. Hypertension (1995) 1.42
The changing clinical spectrum of adrenal insufficiency. Ann Intern Med (1997) 1.38
Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension. J Clin Invest (1998) 1.34
Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. Am J Physiol (1988) 1.33
Hypercalcemia associated with chronic lymphocytic leukemia. Arch Intern Med (1979) 1.33
Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension (1999) 1.33
Rapid adrenocorticotropic hormone test in practice. Retrospective review. Am J Med (1985) 1.31
Toxoplasmosis. Clinical experiences in a cancer hospital. Am J Med (1973) 1.29
Renin and angiotensinogen gene expression in maturing rat kidney. Am J Physiol (1988) 1.26
The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone. Arch Intern Med (1972) 1.23
Measurement of the negative muon anomalous magnetic moment to 0.7 ppm. Phys Rev Lett (2004) 1.19
Renin-angiotensin system modulates renal bradykinin production. Am J Physiol (1996) 1.18
Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats. Hypertension (2000) 1.17
Pericardial tamponade: a major presenting manifestation of hydralazine-induced lupus syndrome. Am J Med (1973) 1.16
The Charlottesville blood pressure survey: the role of the physician in hypertension case finding. Med Care (1977) 1.16
The Charlottesville Blood-Pressure Survey. Value of repeated blood-pressure measurements. JAMA (1976) 1.13
Effect of intrarenal angiotensin II blockade on renal function in conscious dogs. Circ Res (1977) 1.12
Role of the intrarenal renin-angiotensin system in the control of renal function. Circ Res (1981) 1.11
A comparison of natriuresis after oral and intravenous sodium loading in sodium-depleted man: evidence for a gastrointestinal or portal monitor of sodium intake. Clin Sci Mol Med (1975) 1.09
The renal dopamine receptors. J Am Soc Nephrol (1992) 1.09
Angiotensin II type 1 receptor: role in renal growth and gene expression during normal development. Am J Physiol (1994) 1.08
Dopamine(1) receptor, G(salpha), and Na(+)-H(+) exchanger interactions in the kidney in hypertension. Hypertension (2000) 1.07
Differential regulation of renal angiotensin subtype AT1A and AT2 receptor protein in rats with angiotensin-dependent hypertension. Hypertension (1999) 1.05
A comparison on natriuresis after oral and intravenous sodium loading in sodium-depleted rabbits: evidence for a gastrointestinal or portal monitor of sodium intake. Clin Sci Mol Med (1975) 1.04
Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine. J Clin Invest (1980) 1.03
Ectopic secretion of corticotropin-releasing factor as a cause of Cushing's syndrome. A clinical, morphologic, and biochemical study. N Engl J Med (1984) 1.03
Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status. Hypertension (1997) 1.02
Distribution of type-1 and type-2 angiotensin receptors in the normal human lung and in lungs from patients with chronic obstructive pulmonary disease. Histochem Cell Biol (2001) 1.02
Evidence for a splanchnic sodium input monitor regulating renal sodium excretion in man. Lack of dependence upon aldosterone. Circ Res (1978) 1.02
Early streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors. Am J Physiol Renal Physiol (2001) 1.01
Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension. Circulation (1984) 1.01
Response of rat jejunum to angiotensin II: role of norepinephrine and prostaglandins. Am J Physiol (1981) 1.00
Angiotensin II regulates renin gene expression. Am J Physiol (1990) 1.00
Pseudohypoaldosteronism: multiple target organ unresponsiveness to mineralocorticoid hormones. J Clin Endocrinol Metab (1979) 0.99
The renin response to diuretic therapyl A limitation of antihypertensive potential. Circ Res (1978) 0.99
Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone. J Clin Invest (1979) 0.99
Dopamine receptor signaling defects in spontaneous hypertension. Am J Hypertens (1996) 0.99
Gastrointestinal control of sodium excretion in sodium-depleted conscious rabbits. Am J Physiol (1976) 0.99
Regulation of jejunal sodium and water absorption by angiotensin subtype receptors. Am J Physiol (1998) 0.99
The effect of selective dopamine-1 receptor stimulation on renal and adrenal function in man. J Clin Endocrinol Metab (1988) 0.98
Intrarenal dopamine production and distribution in the rat. Physiological control of sodium excretion. Hypertension (1997) 0.98
Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab (1983) 0.98
Localization of angiotensin peptide-forming enzymes of 3T3-F442A adipocytes. Am J Physiol (1993) 0.97
Colocalization and release of angiotensin and renin in renal cortical cells. Am J Physiol (1992) 0.97
Immunolocalization of subtype 2 angiotensin II (AT2) receptor protein in rat heart. Hypertension (1998) 0.96
Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor. J Clin Invest (1999) 0.96
Expression of alpha-smooth muscle actin in the developing kidney vasculature. Hypertension (1992) 0.96
Oxygen regulates vascular endothelial growth factor-mediated vasculogenesis and tubulogenesis. Dev Biol (1997) 0.95
Percutaneous transluminal dilatation of the renal arteries: techniques and results. Radiology (1980) 0.95
Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension. J Clin Invest (1984) 0.95
Localization of the dopamine D1 receptor protein in the human heart and kidney. Hypertension (1997) 0.94
Acute hypoxemia and hypercapnia: increase in plasma catecholamines in conscious dogs. Am J Physiol (1983) 0.94
Ischemic cardiovascular complications concurrent with administration of captopril. A clinical note. Hypertension (1980) 0.94
Interactions between angiotensin peptides and the sympathetic nervous system mediating intestinal sodium and water absorption in the rat. J Clin Invest (1981) 0.94
Identification and differentiation of surgically correctable hypertension due to primary aldosteronism. Am J Med (1979) 0.93
Synergistic effects of acute hypoxemia and hypercapnic acidosis in conscious dogs. Renal dysfunction and activation of the renin-angiotensin system. Circ Res (1983) 0.93
Renin release and gene expression in intact rat kidney microvessels and single cells. J Clin Invest (1990) 0.92
Dopamine D3 receptors in rat juxtaglomerular cells. Clin Exp Hypertens (1997) 0.91
Expression of the dopamine D3 receptor protein in the rat kidney. Hypertension (1998) 0.91
Dopamine D1A receptors and renin release in rat juxtaglomerular cells. Hypertension (1997) 0.90
The Medical Academic Advancement Program at the University of Virginia School of Medicine. Acad Med (1999) 0.90
Control of renal function by intrarenal angiotensin II. Endocrinology (1983) 0.89
Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin II infusion. J Hypertens (2001) 0.89
Selective inhibition of the renal angiotensin type 2 receptor increases blood pressure in conscious rats. Hypertension (2001) 0.88
Localization of dopamine D1A receptor protein in rat kidneys. Am J Physiol (1995) 0.88
Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor. Am J Med (1988) 0.88
Zis: a developmentally regulated gene expressed in juxtaglomerular cells. Am J Physiol (1997) 0.88
Spatial association of renin-containing cells and nerve fibers in developing rat kidney. Pediatr Nephrol (1991) 0.87
Renal interstitial cGMP mediates natriuresis by direct tubule mechanism. Hypertension (2001) 0.87
Antidiuresis and vasopressin release with hypoxemia and hypercapnia in conscious dogs. Am J Physiol (1984) 0.87
Malignant melanoma with ectopic production of adrenocorticotropic hormone. Palliative treatment with inhibitors of adrenal steroid biosynthesis. J Clin Endocrinol Metab (1973) 0.87
Hemodialysis-resistant hypertension: control with an orally active inhibitor of angiotensin-converting enzyme. J Clin Endocrinol Metab (1979) 0.86
Stimulation of intestinal sodium and water transport in vivo by angiotensin II and analogs. Endocrinology (1980) 0.86
Isolation of renin-rich rat kidney cells. Hypertension (1987) 0.86
Decreased plasma and urinary dopamine during dietary sodium depletion in man. J Clin Endocrinol Metab (1981) 0.85
Fetal expression of the angiotensinogen gene. Endocrinology (1988) 0.85
Selective inhibition of the renal dopamine subtype D1A receptor induces antinatriuresis in conscious rats. Hypertension (1999) 0.85
The dopamine agonist bromocriptine induces hypotension by venous and arteriolar dilation. J Cardiovasc Pharmacol (1984) 0.85
In situ localization of renin and its mRNA in neonatal ureteral obstruction. Am J Physiol (1990) 0.84
Demonstration of a primary antidiuretic action of angiotensin II: effects of intrarenal converting enzyme inhibition in the conscious dog. Endocrinology (1981) 0.84
Precise measurement of the positive muon anomalous magnetic moment. Phys Rev Lett (2001) 0.84
Intrarenal dopamine acts at the dopamine-1 receptor to control renal function. J Hypertens Suppl (1988) 0.84
Measurement of the positive muon anomalous magnetic moment to 0.7 ppm. Phys Rev Lett (2002) 0.84
The effects of ovine prolactin on water and electrolyte excretion in man are attributable to vasopressin contamination. J Clin Endocrinol Metab (1977) 0.83
Labile hypertension. Precursor of sustained essential hypertension? Am J Med (1976) 0.83
Escape from the sodium-retaining action of intrarenal angiotensins II and III in the conscious dog. Endocrinology (1985) 0.83
Acute and chronic effect of captropril in hypertensive patients. Hypertension (1980) 0.83
Novel expression and regulation of the renin-angiotensin system in metanephric organ culture. Am J Physiol Regul Integr Comp Physiol (2000) 0.83
Defining the cost of educating undergraduate medical students at the University of Virginia. Acad Med (1997) 0.83